Raderer M - Search Results

1

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.

Petkov V, Mosgoeller W, Ziesche R, Raderer M, Stiebellehner L, Vonbank K, Funk GC, Hamilton G, Novotny C, Burian B, Block LH. Petkov V, et al. Among authors: raderer m. J Clin Invest. 2003 May;111(9):1339-46. doi: 10.1172/JCI17500. J Clin Invest. 2003. PMID: 12727925 Free PMC article.

2

Vasoactive intestinal peptide receptor scintigraphy.

Virgolini I, Kurtaran A, Raderer M, Leimer M, Angelberger P, Havlik E, Li S, Scheithauer W, Niederle B, Valent P, et al. Virgolini I, et al. Among authors: raderer m. J Nucl Med. 1995 Oct;36(10):1732-9. J Nucl Med. 1995. PMID: 7562036 Free article.

3

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.

Virgolini I, Raderer M, Kurtaran A, Angelberger P, Banyai S, Yang Q, Li S, Banyai M, Pidlich J, Niederle B, Scheithauer W, Valent P. Virgolini I, et al. Among authors: raderer m. N Engl J Med. 1994 Oct 27;331(17):1116-21. doi: 10.1056/NEJM199410273311703. N Engl J Med. 1994. PMID: 7935635 Free article. Clinical Trial.

4

Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes.

Drach J, Gsur A, Hamilton G, Zhao S, Angerler J, Fiegl M, Zojer N, Raderer M, Haberl I, Andreeff M, Huber H. Drach J, et al. Among authors: raderer m. Blood. 1996 Sep 1;88(5):1747-54. Blood. 1996. PMID: 8781431 Free article.

5

Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.

Raderer M, Becherer A, Kurtaran A, Angelberger P, Li S, Leimer M, Weinlaender G, Kornek G, Kletter K, Scheithauer W, Virgolini I. Raderer M, et al. J Nucl Med. 1996 Sep;37(9):1480-7. J Nucl Med. 1996. PMID: 8790198 Free article. Clinical Trial.

6

123I-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract.

Virgolini I, Raderer M, Kurtaran A, Angelberger P, Yang Q, Radosavljevic M, Leimer M, Kaserer K, Li SR, Kornek G, Hübsch P, Niederle B, Pidlich J, Scheithauer W, Valent P. Virgolini I, et al. Among authors: raderer m. Nucl Med Biol. 1996 Aug;23(6):685-92. doi: 10.1016/0969-8051(96)00066-2. Nucl Med Biol. 1996. PMID: 8940711

7

Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.

Kurtaran A, Raderer M, Müller C, Prokesch R, Kaserer K, Eibenberger K, Koperna K, Niederle B, Virgolini I. Kurtaran A, et al. Among authors: raderer m. J Nucl Med. 1997 Jun;38(6):880-1. J Nucl Med. 1997. PMID: 9189133 Free article.

8

123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer.

Raderer M, Kurtaran A, Hejna M, Vorbeck F, Angelberger P, Scheithauer W, Virgolini I. Raderer M, et al. Br J Cancer. 1998 Jul;78(1):1-5. doi: 10.1038/bjc.1998.433. Br J Cancer. 1998. PMID: 9662242 Free PMC article.

9

Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancer.

Raderer M, Kurtaran A, Yang Q, Meghdadi S, Vorbeck F, Hejna M, Angelberger P, Kornek G, Pidlich J, Scheithauer W, Virgolini I. Raderer M, et al. J Nucl Med. 1998 Sep;39(9):1570-5. J Nucl Med. 1998. PMID: 9744345 Free article.

10

Expression of human somatostatin receptor subtype 3 in pancreatic cancer in vitro and in vivo.

Raderer M, Pangerl T, Leimer M, Valencak J, Kurtaran A, Hamilton G, Scheithauer W, Virgolini I. Raderer M, et al. J Natl Cancer Inst. 1998 Nov 4;90(21):1666-8. doi: 10.1093/jnci/90.21.1666. J Natl Cancer Inst. 1998. PMID: 9811317 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page